Dyadic International Inc.

DYAI Nasdaq SEC CIK 1213809
Follow Dyadic International Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $449.1K −61.4% vs same quarter last year
Net income −$1.4M +31.3% vs same quarter last year
EPS, diluted −$0.04 +33.3% vs same quarter last year
Operating cash flow −$1.5M +19.9% vs same quarter last year
Revenue by quarter
$817.4K
$393.6K
$966.6K
$1.2M
$565.5K
$1.1M
$961.1K
$449.1K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$15M−$10M−$5M$0$5MFY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$3.1M−$7.4M
FY24$3.5M−$5.8M
FY23$2.9M−$6.8M
FY22$2.9M−$9.7M
FY21$2.4M−$13.1M
FY20$1.6M−$9.3M
FY19$1.7M−$8.3M
FY18$1.3M−$5.7M
FY17$758.4K−$2.1M
FY16--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1000%−500%0%500%FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2524.9%−232.8%−238.3%
FY2465.8%−168.8%−166.2%
FY2331.8%−283.9%−234.4%
FY2227.5%−346.9%−332.2%
FY2119.1%−612.7%−543.7%
FY2011%−625.9%−582.1%
FY1913.2%−552.2%−494.2%
FY1820.7%−586.1%−439.4%
FY1710.3%−939.7%−281.6%
FY16---
Returned to shareholdersDividends paid and shares bought back
$0$2M$4M$6M$8MFY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25-
FY24-
FY23-
FY22-
FY21-
FY20-
FY19$0
FY18$2.3M
FY17$6.2M
FY16-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Dyadic International
  • Healthcare median
−600%−400%−200%0%FY17FY19FY21FY23FY25
Show the numbers
YearDyadic InternationalHealthcare median
FY25−238.3%−30.6%
FY24−166.2%−47%
FY23−234.4%−58%
FY22−332.2%−80.4%
FY21−543.7%−71.8%
FY20−582.1%−62.2%
FY19−494.2%−46.2%
FY18−439.4%−49.6%
FY17−281.6%−45.9%
FY16-−36%